For columnist Desiree Lama, MS Awareness Month is an opportunity for people living with MS to speak their truth about their ...
WEST LAFAYETTE, Ind. — A biomarker for multiple sclerosis that could be an early warning for the disease has shown promise in both human and animal testing. Researchers at Purdue University and the ...
A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease progression that could help identify patients most likely to benefit from new drugs.
For decades, multiple sclerosis (MS) has been defined primarily by its symptoms, rather than its underlying biology. Now, a new study aims to challenge that approach, presenting evidence that MS may ...
Scientists have identified an unusual type of brain cell that may play a vital role in progressive multiple sclerosis (MS), likely contributing to the persistent inflammation characteristic of the ...
A blood-based biomarker assay for multiple sclerosis (MS) disease activity provides actionable insights that supplement standard MS evaluations, especially for treatment initiation and de-escalation ...
People with late-onset MS, who experience their first symptoms after age 50, tend to have faster disability progression, ...
A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease progression that could help identify patients most likely to benefit from new drugs.
Advanced MRI techniques can differentiate between degenerative and reparative processes in MS lesions, offering insights into disease progression. Quantitative MRI (qMRI) provides detailed biophysical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results